Clinical interpretation of changes in serial measurements of patients' HbA(
1c) ought to be based on the knowledge of pre-analytical, analytical and in
tra-individual sources of variation that affect the results. The detectable
change in HbA(1c) percentage depends on total analytical error. Since we h
ave previously evidenced major problems in the routine use of HPLC, we comp
ared a highly automated glycohemoglobin assay with the reference RPLC to so
lve the problem. The within- and between-run coefficients of variations ran
ged from 0.86 to 0.93%, and 2.51 to 2.12%, respectively, for the HPLC, and
from 1.07 to 0.95, and 1.61 to 0.99% for the immunoturbidimetric assay. Aft
er HbA(1c)- assay calibration, the quality-control survey report of duplica
te determinations performed on 20 consecutive days by both the HPLC and the
immunologic method provided the expected mean values of control materials.
The assay of 106 blood samples showed a minor yet significant bias of the
immunoturbidimetric assay toward lower HbA(1c) values (p 0.0001), as previo
usly observed, although the two determination series resulted significantly
correlated (r=0.96,p=0.0001). We conclude that the immunoturbidimetric ass
ay is surely accurate, precise, and reproducible, and represents a valid al
ternative to the reference HPLC assay. (C) 2001, Editrice Kurtis.